European shares rose on Wednesday after sharp declines in the previous session, with Italy’s biggest insurer Generali gaining after committing to boost dividends and enzymes maker Novozymes advancing on a UBS upgrade.
Shares in Generali progressed by 2 per cent after the company said it would pay cumulative dividends of more than €5 billion ($5.5 billion) to the end of 2018, as it focuses on increasing cash generation and building a solid capital base.
Novozymes, the world’s largest maker of industrial enzymes, also rose 2.8 per cent after UBS raised its stance on the stock to “buy’’ from “sell’’.
At 0711 GMT, the FTSEurofirst 300 index of top European shares was up 0.4 per cent at 1,608.86 points after falling to a one-week low in the previous session.
Energy shares were also in demand, with the STOXX Europe 600 Oil and gas index rising 0.4 per cent, as oil prices rebounded on expectations that US crude stocks could fall for a fourth straight week.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.